 David Mirsky
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 44 | 2023 | 3053 | 3.420 |
Why?
| | Hydrocephalus | 6 | 2023 | 81 | 2.450 |
Why?
| | Prenatal Diagnosis | 7 | 2022 | 168 | 2.070 |
Why?
| | Stroke | 14 | 2022 | 1019 | 1.660 |
Why?
| | Brain | 15 | 2022 | 2372 | 1.530 |
Why?
| | Neuroimaging | 9 | 2022 | 248 | 1.270 |
Why?
| | Cerebrospinal Fluid Shunts | 2 | 2020 | 28 | 1.260 |
Why?
| | Craniocerebral Trauma | 4 | 2022 | 128 | 1.200 |
Why?
| | Brain Neoplasms | 7 | 2022 | 987 | 1.050 |
Why?
| | Neural Tube Defects | 2 | 2018 | 61 | 1.040 |
Why?
| | Child | 51 | 2023 | 18366 | 1.010 |
Why?
| | Fetus | 6 | 2022 | 701 | 1.000 |
Why?
| | Child Abuse | 4 | 2023 | 450 | 0.970 |
Why?
| | Head and Neck Neoplasms | 3 | 2022 | 436 | 0.960 |
Why?
| | Nervous System Malformations | 2 | 2023 | 34 | 0.920 |
Why?
| | Central Nervous System Neoplasms | 2 | 2022 | 126 | 0.910 |
Why?
| | Retrospective Studies | 30 | 2023 | 12544 | 0.830 |
Why?
| | Megalencephaly | 1 | 2022 | 15 | 0.830 |
Why?
| | Circle of Willis | 1 | 2022 | 6 | 0.810 |
Why?
| | Dermoid Cyst | 1 | 2022 | 12 | 0.800 |
Why?
| | Epidermal Cyst | 1 | 2022 | 12 | 0.800 |
Why?
| | Contrast Media | 4 | 2022 | 353 | 0.800 |
Why?
| | Nasal Obstruction | 1 | 2021 | 23 | 0.740 |
Why?
| | Neck | 4 | 2022 | 83 | 0.730 |
Why?
| | Infant, Newborn, Diseases | 2 | 2019 | 104 | 0.720 |
Why?
| | Humans | 92 | 2023 | 114937 | 0.720 |
Why?
| | Ependymoma | 1 | 2022 | 157 | 0.710 |
Why?
| | Central Nervous System Infections | 2 | 2018 | 36 | 0.710 |
Why?
| | Tomography, X-Ray Computed | 12 | 2022 | 2326 | 0.710 |
Why?
| | Gadolinium DTPA | 2 | 2019 | 47 | 0.710 |
Why?
| | Intracranial Hemorrhages | 2 | 2019 | 76 | 0.690 |
Why?
| | Temporal Lobe | 1 | 2019 | 79 | 0.660 |
Why?
| | Thrombosis | 1 | 2022 | 297 | 0.660 |
Why?
| | Infant | 18 | 2023 | 7937 | 0.640 |
Why?
| | Cavernous Sinus Thrombosis | 2 | 2015 | 9 | 0.640 |
Why?
| | Anatomic Landmarks | 1 | 2018 | 23 | 0.630 |
Why?
| | Child, Preschool | 25 | 2023 | 9086 | 0.620 |
Why?
| | Occipital Lobe | 1 | 2017 | 23 | 0.590 |
Why?
| | Spinal Cord | 2 | 2021 | 348 | 0.570 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 96 | 0.560 |
Why?
| | Pediatrics | 4 | 2019 | 984 | 0.550 |
Why?
| | Facial Injuries | 1 | 2016 | 19 | 0.550 |
Why?
| | Frontal Lobe | 1 | 2017 | 140 | 0.540 |
Why?
| | Head | 2 | 2019 | 85 | 0.540 |
Why?
| | Carotid Stenosis | 2 | 2015 | 79 | 0.530 |
Why?
| | Brain Diseases | 2 | 2020 | 125 | 0.530 |
Why?
| | Societies, Medical | 6 | 2022 | 677 | 0.530 |
Why?
| | Craniopharyngioma | 3 | 2023 | 65 | 0.530 |
Why?
| | Tissue Adhesions | 1 | 2015 | 25 | 0.520 |
Why?
| | Spinal Injuries | 3 | 2022 | 48 | 0.520 |
Why?
| | Ultrasonography, Prenatal | 3 | 2022 | 236 | 0.510 |
Why?
| | Lymphatic Abnormalities | 2 | 2012 | 18 | 0.510 |
Why?
| | Cerebral Infarction | 1 | 2015 | 39 | 0.500 |
Why?
| | Female | 44 | 2022 | 59581 | 0.500 |
Why?
| | Craniofacial Abnormalities | 2 | 2012 | 59 | 0.500 |
Why?
| | Central Nervous System Diseases | 1 | 2015 | 61 | 0.490 |
Why?
| | Hypothalamus | 1 | 2015 | 147 | 0.490 |
Why?
| | Infant, Newborn | 14 | 2022 | 5035 | 0.480 |
Why?
| | Pregnancy | 12 | 2022 | 5527 | 0.440 |
Why?
| | Dandy-Walker Syndrome | 2 | 2023 | 7 | 0.440 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2023 | 193 | 0.430 |
Why?
| | Goiter | 1 | 2012 | 3 | 0.420 |
Why?
| | Stomatognathic Diseases | 1 | 2012 | 4 | 0.420 |
Why?
| | Male | 34 | 2022 | 55663 | 0.390 |
Why?
| | Meningomyelocele | 2 | 2022 | 55 | 0.380 |
Why?
| | Brain Ischemia | 3 | 2022 | 299 | 0.380 |
Why?
| | Magnetic Resonance Angiography | 3 | 2019 | 221 | 0.380 |
Why?
| | Fetal Diseases | 1 | 2012 | 147 | 0.370 |
Why?
| | Sinusitis | 3 | 2018 | 175 | 0.370 |
Why?
| | Postoperative Complications | 2 | 2018 | 2133 | 0.350 |
Why?
| | Diagnosis, Differential | 7 | 2019 | 1355 | 0.350 |
Why?
| | Sacrum | 3 | 2018 | 65 | 0.350 |
Why?
| | Pituitary Neoplasms | 2 | 2023 | 157 | 0.340 |
Why?
| | Infarction, Middle Cerebral Artery | 3 | 2022 | 38 | 0.330 |
Why?
| | Hypothalamic Diseases | 2 | 2022 | 17 | 0.330 |
Why?
| | Emergency Medical Services | 1 | 2015 | 587 | 0.310 |
Why?
| | Adolescent | 17 | 2023 | 17829 | 0.310 |
Why?
| | Anorectal Malformations | 2 | 2021 | 103 | 0.310 |
Why?
| | Mitochondrial Diseases | 2 | 2020 | 77 | 0.310 |
Why?
| | Evidence-Based Medicine | 6 | 2022 | 675 | 0.300 |
Why?
| | Prenatal Care | 4 | 2022 | 255 | 0.300 |
Why?
| | Prevalence | 3 | 2022 | 2252 | 0.290 |
Why?
| | Teratoma | 2 | 2019 | 92 | 0.290 |
Why?
| | Cerebrovascular Disorders | 2 | 2020 | 82 | 0.270 |
Why?
| | Muscular Diseases | 2 | 2020 | 105 | 0.270 |
Why?
| | Priapism | 1 | 2005 | 10 | 0.260 |
Why?
| | Chloroquine | 2 | 2017 | 52 | 0.250 |
Why?
| | Penis | 1 | 2005 | 37 | 0.250 |
Why?
| | Hematoma, Subdural | 2 | 2022 | 16 | 0.250 |
Why?
| | Gestational Age | 3 | 2022 | 759 | 0.250 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 18 | 0.240 |
Why?
| | Embolization, Therapeutic | 1 | 2005 | 177 | 0.220 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2020 | 30 | 0.220 |
Why?
| | Autophagy | 2 | 2017 | 234 | 0.220 |
Why?
| | Indoles | 2 | 2017 | 306 | 0.220 |
Why?
| | Physical Abuse | 1 | 2023 | 31 | 0.210 |
Why?
| | Surface Plasmon Resonance | 1 | 2022 | 83 | 0.210 |
Why?
| | Neck Injuries | 1 | 2022 | 18 | 0.210 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2022 | 23 | 0.200 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 209 | 0.200 |
Why?
| | Pyrimidinones | 1 | 2023 | 88 | 0.200 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.200 |
Why?
| | Sulfonamides | 2 | 2017 | 445 | 0.200 |
Why?
| | Migraine Disorders | 1 | 2023 | 82 | 0.200 |
Why?
| | Cysts | 1 | 2022 | 93 | 0.200 |
Why?
| | Pyridones | 1 | 2023 | 124 | 0.200 |
Why?
| | White Matter | 1 | 2023 | 102 | 0.190 |
Why?
| | Epilepsy | 2 | 2016 | 277 | 0.190 |
Why?
| | Neuroblastoma | 1 | 2022 | 132 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 62 | 0.190 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 91 | 0.190 |
Why?
| | Methionine | 1 | 2021 | 144 | 0.190 |
Why?
| | Vitamin B 12 | 1 | 2021 | 115 | 0.180 |
Why?
| | Sutures | 1 | 2021 | 52 | 0.180 |
Why?
| | Nasal Cavity | 1 | 2021 | 47 | 0.180 |
Why?
| | Pituitary Diseases | 1 | 2020 | 23 | 0.180 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2020 | 17 | 0.180 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2020 | 35 | 0.180 |
Why?
| | Arnold-Chiari Malformation | 1 | 2020 | 30 | 0.180 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.180 |
Why?
| | Leigh Disease | 1 | 2020 | 17 | 0.180 |
Why?
| | Quinone Reductases | 1 | 2020 | 15 | 0.180 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 64 | 0.170 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.170 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 729 | 0.170 |
Why?
| | Spasms, Infantile | 1 | 2021 | 103 | 0.170 |
Why?
| | Tyrosine | 1 | 2020 | 216 | 0.170 |
Why?
| | RNA, Transfer | 1 | 2020 | 118 | 0.170 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.170 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 182 | 0.170 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2020 | 63 | 0.160 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.160 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.160 |
Why?
| | United States | 10 | 2021 | 12211 | 0.160 |
Why?
| | Taenia solium | 1 | 2018 | 5 | 0.160 |
Why?
| | Neurocysticercosis | 1 | 2018 | 6 | 0.160 |
Why?
| | Foramen Magnum | 1 | 2018 | 9 | 0.160 |
Why?
| | Ilium | 1 | 2018 | 27 | 0.160 |
Why?
| | Soft Tissue Neoplasms | 1 | 2019 | 90 | 0.150 |
Why?
| | Occipital Bone | 1 | 2018 | 18 | 0.150 |
Why?
| | Sphenoid Bone | 1 | 2018 | 15 | 0.150 |
Why?
| | Skull Base | 1 | 2018 | 39 | 0.150 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 101 | 0.150 |
Why?
| | Reference Values | 1 | 2019 | 741 | 0.150 |
Why?
| | Area Under Curve | 1 | 2018 | 275 | 0.150 |
Why?
| | Mitochondria | 2 | 2020 | 751 | 0.150 |
Why?
| | Toxoplasmosis | 1 | 2018 | 30 | 0.150 |
Why?
| | Epilepsies, Partial | 1 | 2018 | 29 | 0.150 |
Why?
| | Radiation Dosage | 1 | 2019 | 136 | 0.150 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 1700 | 0.150 |
Why?
| | Fecal Incontinence | 1 | 2018 | 73 | 0.150 |
Why?
| | Adenoidectomy | 1 | 2018 | 61 | 0.150 |
Why?
| | Central Nervous System | 2 | 2022 | 238 | 0.150 |
Why?
| | Olfaction Disorders | 1 | 2018 | 50 | 0.150 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 6 | 0.150 |
Why?
| | Radiology | 1 | 2020 | 193 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 45 | 0.140 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2018 | 121 | 0.140 |
Why?
| | Herpes Simplex | 1 | 2018 | 87 | 0.140 |
Why?
| | Common Data Elements | 1 | 2017 | 10 | 0.140 |
Why?
| | Seizures | 2 | 2021 | 340 | 0.140 |
Why?
| | ROC Curve | 1 | 2018 | 448 | 0.140 |
Why?
| | Coccyx | 1 | 2017 | 5 | 0.140 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 6 | 0.140 |
Why?
| | Cerebral Arteries | 1 | 2017 | 55 | 0.140 |
Why?
| | Fetal Movement | 1 | 2016 | 6 | 0.140 |
Why?
| | Fetal Monitoring | 1 | 2016 | 16 | 0.140 |
Why?
| | Zika Virus Infection | 1 | 2018 | 83 | 0.140 |
Why?
| | Osteomyelitis | 1 | 2018 | 102 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 126 | 0.140 |
Why?
| | Diazepam | 1 | 2016 | 26 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 265 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 517 | 0.140 |
Why?
| | Organ Size | 1 | 2017 | 435 | 0.140 |
Why?
| | Olfactory Bulb | 1 | 2018 | 123 | 0.140 |
Why?
| | Spondylolysis | 1 | 2016 | 7 | 0.140 |
Why?
| | Anti-Anxiety Agents | 1 | 2016 | 43 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2020 | 686 | 0.130 |
Why?
| | Balamuthia mandrillaris | 1 | 2015 | 4 | 0.130 |
Why?
| | Amebiasis | 1 | 2015 | 5 | 0.130 |
Why?
| | Genome, Microbial | 1 | 2015 | 7 | 0.130 |
Why?
| | Fracture Fixation | 1 | 2016 | 76 | 0.130 |
Why?
| | Third Ventricle | 1 | 2015 | 14 | 0.130 |
Why?
| | Intracranial Thrombosis | 1 | 2015 | 17 | 0.130 |
Why?
| | Cytomegalovirus Infections | 1 | 2018 | 183 | 0.130 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 96 | 0.130 |
Why?
| | Software | 1 | 2020 | 537 | 0.130 |
Why?
| | Hamartoma | 1 | 2015 | 21 | 0.130 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 27 | 0.130 |
Why?
| | Eye Infections, Fungal | 1 | 2015 | 6 | 0.130 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 89 | 0.130 |
Why?
| | Endocrine System Diseases | 1 | 2015 | 30 | 0.130 |
Why?
| | Headache | 3 | 2023 | 132 | 0.130 |
Why?
| | Perioperative Care | 1 | 2016 | 126 | 0.130 |
Why?
| | Orbital Cellulitis | 1 | 2015 | 14 | 0.130 |
Why?
| | Onchocerciasis | 1 | 2015 | 7 | 0.130 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 13 | 0.130 |
Why?
| | Eye Infections, Bacterial | 1 | 2015 | 26 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2017 | 642 | 0.120 |
Why?
| | Pyridoxine | 1 | 2015 | 28 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.120 |
Why?
| | Spinal Cord Diseases | 1 | 2015 | 39 | 0.120 |
Why?
| | Vitamin B Complex | 1 | 2015 | 38 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 1897 | 0.120 |
Why?
| | Emergencies | 1 | 2015 | 146 | 0.120 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 300 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2017 | 194 | 0.120 |
Why?
| | Paralysis | 1 | 2015 | 67 | 0.120 |
Why?
| | Cranial Nerve Diseases | 1 | 2014 | 42 | 0.120 |
Why?
| | Paraplegia | 1 | 2014 | 52 | 0.120 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 211 | 0.120 |
Why?
| | Hippocampus | 1 | 2018 | 696 | 0.120 |
Why?
| | Cerebral Arterial Diseases | 1 | 2014 | 42 | 0.120 |
Why?
| | Fetal Therapies | 1 | 2014 | 30 | 0.120 |
Why?
| | Adult | 7 | 2023 | 30608 | 0.120 |
Why?
| | Nervous System Diseases | 1 | 2017 | 252 | 0.110 |
Why?
| | Encephalitis | 1 | 2015 | 127 | 0.110 |
Why?
| | Arginine | 1 | 2015 | 237 | 0.110 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 115 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1440 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 55 | 0.110 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 109 | 0.110 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2015 | 224 | 0.110 |
Why?
| | Enterovirus D, Human | 1 | 2014 | 72 | 0.110 |
Why?
| | Lysine | 1 | 2015 | 242 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1893 | 0.110 |
Why?
| | Otitis Media | 1 | 2015 | 143 | 0.110 |
Why?
| | Developmental Disabilities | 1 | 2015 | 239 | 0.110 |
Why?
| | Pharyngeal Diseases | 1 | 2012 | 12 | 0.100 |
Why?
| | HIV Infections | 2 | 2018 | 2470 | 0.100 |
Why?
| | Logistic Models | 1 | 2017 | 1844 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2016 | 534 | 0.100 |
Why?
| | Enterovirus Infections | 1 | 2014 | 160 | 0.100 |
Why?
| | Cranial Fossa, Posterior | 2 | 2022 | 17 | 0.100 |
Why?
| | Amino Acids | 1 | 2015 | 449 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2018 | 3008 | 0.100 |
Why?
| | Mutation | 5 | 2021 | 3354 | 0.090 |
Why?
| | Incidence | 1 | 2017 | 2316 | 0.090 |
Why?
| | Brain Injuries | 1 | 2015 | 452 | 0.090 |
Why?
| | Disease Progression | 1 | 2017 | 2392 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1477 | 0.090 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 53 | 0.090 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 380 | 0.090 |
Why?
| | Ultrasonography | 2 | 2021 | 633 | 0.090 |
Why?
| | Herpes Zoster | 1 | 2014 | 333 | 0.080 |
Why?
| | Cerebellum | 2 | 2022 | 200 | 0.080 |
Why?
| | Physical Examination | 2 | 2023 | 220 | 0.080 |
Why?
| | Brain Stem | 2 | 2023 | 101 | 0.080 |
Why?
| | Cervical Vertebrae | 2 | 2022 | 106 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 3344 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2542 | 0.070 |
Why?
| | Family | 2 | 2021 | 590 | 0.070 |
Why?
| | Cerebrospinal Fluid | 2 | 2018 | 90 | 0.070 |
Why?
| | Risk Factors | 4 | 2022 | 8637 | 0.070 |
Why?
| | Recurrence | 2 | 2022 | 937 | 0.070 |
Why?
| | Cohort Studies | 1 | 2015 | 4903 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2022 | 4427 | 0.060 |
Why?
| | Drug Synergism | 2 | 2017 | 316 | 0.060 |
Why?
| | Angiography | 1 | 2005 | 176 | 0.060 |
Why?
| | Endarterectomy, Carotid | 1 | 2004 | 42 | 0.060 |
Why?
| | Young Adult | 2 | 2018 | 10478 | 0.060 |
Why?
| | Spinal Fractures | 1 | 2005 | 76 | 0.060 |
Why?
| | Algorithms | 2 | 2022 | 1474 | 0.060 |
Why?
| | Radiography, Interventional | 1 | 2004 | 110 | 0.060 |
Why?
| | Phenotype | 2 | 2021 | 2817 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2004 | 180 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 6218 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 35 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 12 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 37 | 0.050 |
Why?
| | Wounds, Gunshot | 1 | 2005 | 188 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 27 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 223 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 16 | 0.050 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 19 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2022 | 171 | 0.050 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 39 | 0.050 |
Why?
| | Retinal Hemorrhage | 1 | 2021 | 18 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 129 | 0.050 |
Why?
| | Homocysteine | 1 | 2021 | 136 | 0.050 |
Why?
| | Stents | 1 | 2004 | 476 | 0.050 |
Why?
| | Neuroradiography | 1 | 2020 | 3 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 39 | 0.040 |
Why?
| | Radiography | 1 | 2023 | 819 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 217 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 103 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2770 | 0.040 |
Why?
| | Anal Canal | 1 | 2021 | 83 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 27 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 156 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 93 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2020 | 262 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 188 | 0.040 |
Why?
| | Sacrococcygeal Region | 1 | 2019 | 5 | 0.040 |
Why?
| | Skull Fractures | 1 | 2019 | 29 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 57 | 0.040 |
Why?
| | Radiation Exposure | 1 | 2019 | 40 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 764 | 0.040 |
Why?
| | Antibodies, Helminth | 1 | 2018 | 6 | 0.040 |
Why?
| | Diaper Rash | 1 | 2018 | 4 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 56 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 2725 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 451 | 0.040 |
Why?
| | Kallmann Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
| | Hemispherectomy | 1 | 2018 | 3 | 0.040 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2018 | 15 | 0.040 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2018 | 30 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2017 | 2199 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 71 | 0.040 |
Why?
| | Urinary Incontinence | 1 | 2018 | 56 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2018 | 292 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 472 | 0.040 |
Why?
| | Constipation | 1 | 2018 | 76 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 995 | 0.040 |
Why?
| | Meningitis | 1 | 2018 | 74 | 0.040 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 290 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 441 | 0.040 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2017 | 3 | 0.040 |
Why?
| | Trauma Centers | 1 | 2019 | 325 | 0.040 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 225 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 927 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2020 | 516 | 0.030 |
Why?
| | Rhinitis | 1 | 2018 | 128 | 0.030 |
Why?
| | Eosinophilia | 1 | 2018 | 186 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 737 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1555 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 448 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 9105 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 2016 | 52 | 0.030 |
Why?
| | Oximetry | 1 | 2016 | 81 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 362 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 77 | 0.030 |
Why?
| | Mucormycosis | 1 | 2015 | 20 | 0.030 |
Why?
| | Diet Therapy | 1 | 2015 | 36 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1361 | 0.030 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2015 | 57 | 0.030 |
Why?
| | Metagenomics | 1 | 2015 | 131 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 154 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 1961 | 0.030 |
Why?
| | Data Collection | 1 | 2017 | 623 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2015 | 142 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1022 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 2015 | 127 | 0.030 |
Why?
| | Visual Acuity | 1 | 2015 | 274 | 0.030 |
Why?
| | Animals | 3 | 2021 | 31839 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 478 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 191 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4407 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 372 | 0.030 |
Why?
| | Acute Disease | 1 | 2015 | 915 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1801 | 0.030 |
Why?
| | Branchial Region | 1 | 2012 | 33 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 954 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2359 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1325 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 309 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2891 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2015 | 458 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1472 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1080 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 336 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4091 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 932 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 585 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 949 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 846 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2514 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6125 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4635 | 0.020 |
Why?
| | Aged | 2 | 2019 | 19122 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2005 | 19 | 0.020 |
Why?
| | Catheterization | 1 | 2004 | 160 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 26806 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 6364 | 0.010 |
Why?
|
|
Mirsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|